Rephine helped transform our facility into a GMP compliant site ready for FDA inspection. Their expertise not only ensured compliance but also gave our teams the knowledge and confidence tosustain high-quality standards as we expand into OTC product manufacturing.
Client Testimonial
About this Case Study
A global cosmetics manufacturer, aiming to expand into the pharmaceutical space with over-the-counter (OTC) products, faced a critical challenge: achieving compliance with stringent US GMP (21 CFR 210–211) and FDA requirements. With limited internal GMP expertise, the site needed end-to-end guidance to prepare for inspection readiness and sustainable compliance.
Rephine partnered with the client to deliver a 12-month programme covering gap assessment, remediation, compliance readiness, and knowledge transfer. The result was a facility transformed into a GMP-compliant, FDA-ready site with empowered teams and a strengthened quality culture.
Key outcomes included:
- Successful FDA inspection readiness and site qualification for OTC production
- Expanded market access through new product opportunities
- Enhanced GMP knowledge and reduced compliance risks
- Sustainable quality culture embedded across departments
✅ Download the full case study to discover:
- How Rephine guided the site through GMP gap assessment and remediation
- The strategies used to achieve FDA inspection readiness within 12 months
- How compliance maturity enabled long-term growth and market expansion
Result: A compliant, inspection-ready site enabling OTC manufacturing and new business opportunities.
Download the Case Study
View other our other resources and company news
Article Veterinary GMP in Europe: New Dedicated Framework & VICH GL60 Guide
The EU veterinary sector enters a new era on 16 July 2026. Dedicated GMP regulations replace EudraLex Volume 4 for veterinary products. Learn what changes ...
Read More
Article MDR & IVDR Compliance: A Strategic Approach for MedTech
Regulatory compliance under MDR and IVDR has moved beyond documentation to become a strategic discipline that shapes every stage of a medical device's lifecycle. This ...
Read More
Medical Device MDR & IVDR Compliance as a Business Outcome
Rephine's 2026 White Paper on MDR & IVDR compliance: strategic guidance for MedTech companies to reduce regulatory risk, avoid delays, and reach the EU market ...
Read More
Case Study Full GMP Internal Audit Program Executed On Time
A pharmaceutical manufacturer needed to complete their annual EU GMP internal audit cycle across 11 departments, without the internal capacity to do it. See how ...
Read More
QMS From local to global: scaling your QMS for UK–EU operations
Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
QMS Scale Your Quality System from UK to EU Without Losing Control
Learn how UK life sciences companies can scale their quality management system into EU markets without losing compliance, visibility, or operational control.
Read More
Article Pharmaceutical Equipment Qualification & Control System Validation
Qualifying process equipment and control systems is fundamental to GMP compliance. This guide breaks down how to define user requirements, apply risk-based testing, and maintain ...
Read More
Case Study GMP Consultancy for a New Cannabis Manufacturing Plant
A start up cannabis manufacturer partnered with Rephine to design a GMP compliant facility, implement a practical Quality Management System and prepare for EU GMP ...
Read More
Article How an Internal Services Audit Can Maximise Your Regulatory Compliance
Internal services audits play a critical role in maintaining GMP compliance and driving continuous improvement. This article explores how structured gap assessments, internal audits and ...
Read More
